(Total Views: 445)
Posted On: 07/08/2022 9:45:20 PM
Post# of 153815
Yea why would we want to fund a phase 3?
Oh we let NASH go to a third party ? Who cares there’s only 1000009 other indications.
Yea I’m with management. Focus on the BLA and look for partnerships for the other trials we need to do.
Almost all of are problems can be solved once the BLA is completed. We will know more before the year is over. It’s actually possible it gets filed this year.
So yes nobody wants more shares issued. But who knows we might not even use them. If we don’t authorize more shares then we are in a bad spot to negotiate.
I think we are in a great spot to negotiate as long as the lights are on. We have two trials that hit end points this year. mTNBC and NASH. One or both will most definitely get a partners. That’s a no brainer. Don’t let people convince you that this isn’t on the table. I call bullshit.
We also have the basket trial that’s almost done correct?
Oh we let NASH go to a third party ? Who cares there’s only 1000009 other indications.
Yea I’m with management. Focus on the BLA and look for partnerships for the other trials we need to do.
Almost all of are problems can be solved once the BLA is completed. We will know more before the year is over. It’s actually possible it gets filed this year.
So yes nobody wants more shares issued. But who knows we might not even use them. If we don’t authorize more shares then we are in a bad spot to negotiate.
I think we are in a great spot to negotiate as long as the lights are on. We have two trials that hit end points this year. mTNBC and NASH. One or both will most definitely get a partners. That’s a no brainer. Don’t let people convince you that this isn’t on the table. I call bullshit.
We also have the basket trial that’s almost done correct?
(4)
(1)
